Arcellx Inc ACLX

NAS: ACLX | ISIN: US03940C1009   20/06/2025
63,00 USD (-1,28%)
(-1,28%)   20/06/2025

29 februari 2024 · Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference · Persbericht

28 februari 2024 · Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights · Persbericht

8 december 2023 · Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA (anito-cel) Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at ASH · Persbericht

2 november 2023 · Arcellx Announces Oral Presentation for Its CART-ddBCMA Phase 1 Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 65th ASH Annual Meeting and Exposition · Persbericht

26 oktober 2023 · Arcellx to Participate in Two Upcoming Investor Conferences · Persbericht

14 augustus 2023 · Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results · Persbericht

20 juni 2023 · Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program · Persbericht

8 mei 2023 · Arcellx Provides First Quarter Financial Results · Persbericht

13 april 2023 · Arcellx to Participate at the Canaccord Genuity 2023 Horizons in Oncology Virtual Conference · Persbericht

29 maart 2023 · Arcellx Provides Fourth Quarter and Year-End 2022 Financial Results and Business Highlights · Persbericht

21 februari 2023 · Arcellx to Participate at the H.C. Wainwright Cell Therapy Virtual Conference · Persbericht

2 februari 2023 · Arcellx to Participate in Upcoming Investor Conferences · Persbericht

9 december 2022 · Arcellx Announces Continued Robust Long-Term Responses from its CART-ddBCMA Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma and Additional Pipeline Progress · Persbericht

9 december 2022 · Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma · Persbericht

14 november 2022 · Arcellx Reports Third Quarter 2022 Financial Results and Business Progress · Persbericht

15 augustus 2022 · Arcellx Provides Business Highlights and Reports Second Quarter 2022 Financial Results · Persbericht

Mijn selecties